SymCel’s calScreener™ technology is going in nine locations across five different countries in a mixture of university institutions and pharmaceutical companies. The nine include four signings in Sweden, two signings in Switzerland, and one each in Holland, South Africa, Germany and South East Asia
Scientific data published in The Biotechnology Journal shows that CalScreener’s isothermal microcalorimetry label free well plate assay technology provides new information in the study of tumorous micro tissues, bacteria and parasitic worms, while at the same time providing continuous, real-time biological data.
In Sweden, the technology is being used for assay testing in metabolic research, therapeutic antibody development, malaria and fresh water quality, according to SymCel. The calScreener™ is being utilized for toxicology testing in Germany, and in Holland, the tool is aiding in bacterial and biofilm development for the treatment of bacterial infections with antibiotics. The assay technology also is being applied in South Africa to the study of turberculosis.
“We are very pleased that the life science community is taking advantage of our innovative calScreener™ technology for highly accurate and reliable assay testing,” says Symcel CEO Christer Wallin.